Detection of tumour-specific CD8+ T-cells in the blood of glioblastoma patients

BruCells is collaborating with Professor De Witte from ULB for the preclinical study in which circulating tumour-specific CD8+ T-cells will be detected in the blood of newly diagnosed glioblastoma patients and from which data will be obtained.

In order to obtain the blood samples and tumour biopsies from the glioblastoma patients, a file has been submitted to the Ethics Committee of the Erasme Hospital and has been recently approved.

created over 15 years ago (24 February 2010)    last modified over 11 years ago (3 June 2013)   [ RDF ]   [ RelFinder ]